Evidence map›Paper›PMID 12743366›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2003

Golgi-dependent transport of cholesterol to the Chlamydia trachomatis inclusion.

Reynaldo A Carabeo, David J Mead, Ted Hackstadt

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2003. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 150 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
150citing papers in PubMed, 1 pooled it
6.9field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

150 citing papers in PubMed, 1 synthesis or guideline pooled it, 266 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Frontiers in microbiology · 2024
    Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Cellular cholesterol licensesMicrobial cell (Graz, Austria) · 2023
    Article
  12. Establishing the intracellular niche of obligate intracellular vacuolar pathogens.Frontiers in cellular and infection microbiology · 2023
    Review
  13. Article
  14. Article
  15. Article
  16. Genetic susceptibility loci forFrontiers in immunology · 2022
    Article
  17. Review
  18. Article
  19. Article
  20. The Small Molecule H89 InhibitsInfection and immunity · 2021
    Article

90 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 1 country.

Reynaldo A CarabeoHost-Parasite Interactions Section, Laboratory of Intracellular Parasites, National Institute of Allergy and Infectious Diseases, National Institutes of Health Rocky Mountain Laboratories, Hamilton, MT 59840, USA.
David J Mead
Ted Hackstadt
National Institute of Allergy and Infectious Diseases · USNational Institutes of Health · USNTL Institute for Applied Behavioral Science · US

Funding

Cellular Biology Of Host/parasite InteractionsZIAAI000567 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI HACKSTADT, TED · 2009 to 2025
$16.3M
RICKETTSIAL SURFACE STRUCTURE AND FUNCTIONZ01AI000567 · NIAID · NIAID EXTRAMURAL ACTIVITIES · PI HACKSTADT, DAVID (TED) · 1991 to 2008
$2.5M
6 · The paper itself

Abstract

Cholesterol, a lipid not normally found in prokaryotes, was identified in purified Chlamydia trachomatis elementary bodies and in the chlamydial parasitophorous vacuole (inclusion) membrane of infected HeLa cells. Chlamydiae obtained eukaryotic host cell cholesterol both from de novo synthesis or low-density lipoprotein. Acquisition of either de novo-synthesized cholesterol or low-density lipoprotein-derived cholesterol was microtubule-dependent and brefeldin A-sensitive, indicating a requirement for the Golgi apparatus. Transport also required chlamydial protein synthesis, indicative of a pathogen-directed process. The cholesterol trafficking pathway appears to coincide with a previously characterized delivery of sphingomyelin to the inclusion in that similar pharmacological treatments inhibited transport of both sphingomyelin and cholesterol. These results support the hypothesis that sphingomyelin and cholesterol may be cotransported via a Golgi-dependent pathway and that the chlamydial inclusion receives cholesterol preferentially from a brefeldin A-sensitive pathway of cholesterol trafficking from the Golgi apparatus to the plasma membrane.

Indexed as

AnimalsBiological TransportCell LineChlamydia trachomatisCHO CellsCholesterolCricetinaeGolgi ApparatusHeLa CellsHumansMicroscopy, FluorescenceSphingomyelinsCholesterolSphingomyelins

Identifiers

PMID12743366
PMCPMC164522
OpenAlexW1988642500

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.